Showing results (11-20 of 201) with videos related to
Sort By:
Pageof 21
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.Expert Review of Anticancer Therapy|March 13, 2013
The place of pemetrexed in the management of non-small-cell lung cancer patientsPascale Tomasini, Laurent Greillier, Nataliya Khobta, et al.Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.Current Oncology Reports|August 18, 2020
Immune Oncology Biomarkers in Lung Cancer: an OverviewCamille Travert, Fabrice Barlesi, Laurent Greillier, et al.Expert Review of Anticancer Therapy|December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancerArnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 13, 2025
Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysisYohann Vincent, Faustine Enoch, Vanessa Pauly, et al.Respiratory Medicine and Research|August 25, 2024
Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective studyAlice Goga, Alex Fourdrain, Paul Habert, et al.Therapeutic Advances in Respiratory Disease|February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastasesPascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.Cancers|December 17, 2024
Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of ImmunotherapyAlice Daumas, Celestin Bigarre, Mohamed Boucekine, et al.CPT: Pharmacometrics & Systems Pharmacology|November 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patientsSophie Marolleau, Alice Mogenet, Clara Boeri, et al.Pageof 21